MedPath

A clinical trial to study the effects of a lactobacilli preparation in bacterial vaginosis, HIV infectivity and vaginal immunity in healthy women and in subjects with bacterial vaginosis

Phase 3
Completed
Registration Number
CTRI/2007/091/000022
Lead Sponsor
CD Pharma India Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
140
Inclusion Criteria

Healthy women of reproductive age group over 18 years

Bacterial vaginosis to be excluded by Nugent score (healthy patients)

b.Bacterial vaginosis diagnosis is based on the Nugent method (in patients with bacterial vaginosis)

Exclusion of any other vaginal infection by standard diagnostic procedure.

Written informed consent

Exclusion Criteria

Post menopausal women
Pregnant women
Abnormal uterine bleeding (not including cervical contact bleeding on sampling) or vaginal bleeding of unknown origin.
AIDS patients or patients with any kind of cancer or tumor
Diabetes mellitus
Drug addiction
Antibiotic use (local or systemic) in the previous 20 days.
Use of any vaginal medication in the previous 7 days.
Participation in any other study 30 days before beginning of the present study.
Known or suspected hypersensitivity to any of the ingredients of the trial medication.
No informed consent.
Patient not willing to comply with the trial instructions.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath